RSS Feeds
Drug Interaction of Terfenadine and Carbamazepine
- Steven Hirschfeld, MD; and
- Paul Jarosinski, MD
The Editors welcome submissions for possible publication in the Letters section. Authors of letters should:
Include no more than 300 words of text, three authors, and five references
Type with double-spacing
Send three copies of the letter, an authors' form signed by all authors, and a cover letter describing any conflicts of interest related to the contents of the letter.
Letters commenting on an Annals article will be considered if they are received within 6 weeks of the time the article was published. Only some of the letters received can be published. Published letters are edited and may be shortened; tables and figures are included only selectively. Authors will be notified that the letter has been received. If the letter is selected for publication, the author will be notified about 3 weeks before the publication date. Unpublished letters cannot be returned.
Annals welcomes electronically submitted letters.
TO THE EDITOR:
We observed a drug interaction between the antihistamine terfenadine (Seldane, Marion Merrell Dow, Kansas City, Missouri) and the anticonvulsant carbamazepine (Tegretol, Basel Pharmaceuticals, Summit, New Jersey) that warrants the attention of practitioners.
An 18-year-old woman (weight, 39.3 kg) who had had hip disarticulation for osteosarcoma and who was on anticonvulsant therapy after treatment of brain metastases came to the hospital with symptoms of confusion, disorientation, visual hallucinations, nausea, and ataxia. Her history was unremarkable for recent infections, ingestion, or trauma. She had a history of atopy, and her symptoms began shortly after taking terfenadine, 60 mg twice daily by mouth, for symptomatic relief of rhinitis. A serum level of carbamazepine was 8.9 mg/L (normal, 4 to 12 mg/L). Because terfenadine and carbamazepine are highly protein bound, we speculated that the terfenadine had displaced the carbamazepine, resulting in a higher than normal free carbamazepine level, which we tested for at an outside laboratory. We withheld further terfenadine and the symptoms cleared. The free carbamazepine level results were returned later in the week at 6.0 mg/L, almost three times the upper limit of normal (normal, 1.6 to 2.2 mg/L). After discontinuing terfenadine, her free carbamazepine level returned to within the normal range (2.1 mg/L), whereas the total level remained at 8.9 mg/L.
We could find no other report of this potentially dangerous complication of concomitant therapy with terfenadine and carbamazepine.
- Copyright 2004 by the American College of Physicians
